Our Research

Publications from USDAR
Blumenthal KG, Harkness T, Phillips EJ, Ramsey A, Banerji A, Samarakoon U, Stone C, Fu X, Khan DA, Otani I, Camargo CA Jr, Zhang Y, Donelan K; USDAR Study Team
Journal of Allergy and Clinical Immunology: In Practice, 2020
Although thousands of Americans are evaluated for a drug allergy every year, there is still very little information about who is getting tested and what their concerns about allergy testing are. In this study, USDAR Principal Investigator, Dr. Blumenthal, led an analysis of USDAR data, using mixed qualitative and quantitative methods to uncover significant associations between patient characteristics and concerns. With this knowledge, allergy clinicians can better understand their patients’ concerns and start to address the roots of those concerns.
Blumenthal KG, Ramsey A, Samarakoon U, Otani I, Gonzalez-Estrada A, Banerji A, Liu A, Wickner P, Stone C, Park M, Mancini C, Judd A, Ahola C, Fu X, Zhang Y, Donelan K, Mustafa SS, Blue H, Sheflin D, Harkness T, Khan D, Garzon-Siatoya W, Morgenstern-Kaplan D, Marks M, Kerrigan A, Rukasin C, Phillips E
Journal of Allergy and Clinical Immunology: In Practice, 2022
Featured Poster Presentation, 2022 Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
After collecting and analyzing data from over 1,000 USDAR participants who underwent a testing procedure for penicillin allergy, we demonstrated that the vast majority of penicillin allergy labels are disproved with formal testing. The publication of these results was selected for a featured poster presentation to allergists and immunologists from across the United States at the 2022 Annual Meeting of the American Academy of Allergy, Asthma, and Immunology (AAAAI), the leading national professional organization in allergy and immunology.